Vitalah intros sports drink that supports energy, stamina and recovery
SANTA CRUZ, Calif. — Vitalah, creators of Oxylent, recently introduced a comprehensive 3-in-1 supplement drink called Sport Oxylent that supports energy, stamina and recovery through its formulation of micronutrients designed for athletes, sports enthusiasts or anyone with an active lifestyle .
“We’re offering the highest quality cutting-edge ingredients on the market that are backed by science and available in the most absorbable form for the body’s use," stated Lisa Lent, CEO of Vitalah. "You can feel the difference when you drink Sport Oxylent — that’s because it offers a natural burst of energy that gives the mind and body the stamina it needs to go the distance.”
With a unique panel of ingredients that includes Creatine MagnaPower, Sustamine, Citrulline Malate, SOD, Superfruit AuroraBlue blueberry, electrolytes, antioxidants, vitamins C, D, B6 and B12, and a host of Albion minerals, this product is the all-in-one solution for pre-, during and post-workout support, the company stated. Sport Oxylent is free of sugar, gluten, soy, dairy, GMOs or caffeine. Sweetened with natural stevia, the product has zero calories.
Available in convenient 30-serving canisters or 15-count stick pack boxes, Sport Oxylent makes a refreshing drink in a Blueberry Burst flavor.
CDC, AMA launch Prevent Diabetes STAT program
CHICAGO — With more than 86 million Americans living with prediabetes and nearly 90% of them unaware of it, the American Medical Association and the Centers for Disease Control and Prevention on Thursday announced that they have joined forces to take urgent action to Prevent Diabetes STAT and urge others to join in this critical effort.
“It’s time that the nation comes together to take immediate action to help prevent diabetes before it starts,” stated AMA president Robert Wah. “Type 2 diabetes is one of our nation’s leading causes of suffering and death — with one out of three people at risk of developing the disease in their lifetime. To address and reverse this alarming national trend, America needs frontline physicians and other healthcare professionals, as well as key stakeholders such as employers, insurers and community organizations to mobilize and create stronger linkages between the care delivery system, our communities, and the patients we serve.”
“The time to act is now. We need a national, concerted effort to prevent additional cases of type 2 diabetes in our nation — and we need it now,” said Ann Albright, director of CDC’s Division of Diabetes Translation. “We have the scientific evidence and we’ve built the infrastructure to do something about it, but far too few people know they have prediabetes and that they can take action to prevent or delay developing type 2 diabetes.”
Prevent Diabetes STAT: Screen, Test, Act – Today, is a multi-year initiative that expands on the work each organization has already begun to reach more Americans with prediabetes and stop the progression to type 2 diabetes. Through this initiative, the AMA and CDC are sounding an alarm and shining a light on prediabetes as a critical and serious medical condition.
People with prediabetes have higher-than-normal blood glucose levels but not high enough yet to be considered type 2 diabetes. Research shows that 15%-to-30% of overweight people with prediabetes will develop type 2 diabetes within five years unless they lose weight through healthy eating and increased physical activity.
As an immediate result of this partnership, the AMA and CDC have codeveloped a toolkit to serve as a guide for physicians and other healthcare providers on the best methods to screen and refer high-risk patients to diabetes prevention programs in their communities.
There is also an online screening tool for patients at www.preventdiabetesstat.org to help them determine their risk for type 2 diabetes.
“This initiative is also about empowering patients to take control of their health,” Wah said. “It starts with knowing your risk factors.”
Over the past two years, both the CDC and the AMA have been laying the groundwork for this national effort. In 2012, the CDC launched its National Diabetes Prevention Program (based on research led by the National Institutes of Health, which showed that high-risk individuals who participated in lifestyle change programs like those recognized by the CDC saw a significant reduction in the incidence of type 2 diabetes). Today, there are more than 500 of these programs across the country, including online options.
The AMA launched its Improving Health Outcomes initiative in 2013 aimed at preventing both type 2 diabetes and heart disease. That work includes a partnership with the YMCA of the USA to increase the number of physicians who screen patients for prediabetes and refer them to diabetes prevention programs offered by local YMCAs that are part of the CDC’s recognition program. This joint effort included 11-physician practice pilot sites in four states, where care teams helped to inform the development of the AMA and CDC’s toolkit. In the coming months, the AMA will be identifying states in which to strengthen the linkages between the clinical care setting and communities to reduce the incidence of diabetes
“Our healthcare system simply cannot sustain the continued increases in the number of people developing diabetes.” Albright said. “Screening, testing and referring people at risk for type 2 diabetes to evidence-based lifestyle change programs are critical to preventing or delaying new cases of type 2 diabetes.”
“Long term, we are confident that this important and necessary work will improve health outcomes and reduce the staggering burden associated with the public health epidemic of type 2 diabetes,” Wah added.
Survey: Self-care access to APAP for pain relief important to consumers
WASHINGTON — Consumers want to maintain nonprescription access to the pain reliever acetaminophen, according to a new Alliance for Aging Research survey of 1,600 Americans ages 18 and over.
Due to concerns regarding misuse and unintentional overdose of acetaminophen, the U.S. Food and Drug Administration has considered restricting access to some OTC medications containing acetaminophen, including the potential of requiring a prescription for products that are currently available OTC, the alliance noted.
However, according to the survey:
- 77% of those under age 60 and 68% of those over age 60 prefer consumer education to government restriction as a way to protect people from acetaminophen overdose;
- 75% of respondents under age 60 and 70% of respondents over age 60 believe that the FDA should not change its policies to require a doctor’s prescription to buy extra-strength Tylenol or an equivalent store brand;
- 52% of those under age 60 and 45% over age 60 believe that requiring a prescription will make it more difficult to access safe pain medications;
- Only 11% of those under age 60 and 19% over age 60 would go to a doctor for an acetaminophen prescription; and
- 40% of those under age 60 and 30% of those over age 60 would stop using Tylenol or an equivalent store brand and change to a different pain reliever. This is significant because some of these respondents reported having been diagnosed with conditions in which other pain relievers may not be appropriate, including cardiovascular disease, diabetes, liver disease, kidney disease, renal dysfunction, ulcers, acid reflux or GERD.
“The aging of our population means that more Americans will be faced with persistent pain,” stated Cynthia Bens, VP public policy for the Alliance for Aging Research. “Potential barriers to OTC medication access may have unintended health consequences for seniors who rely on OTC pain relievers that contain acetaminophen to reduce their pain and maintain their quality of life.”
The survey also offered insights into the amount of pain people experience. More than 18% of respondents age 60 and over encounter bad or severe pain, and more than 37% have daily pain. As many as 70% of this age group uses OTC pain medication. And for those under age 60, bad or severe pain is experienced by 15%, while 25% experience daily pain. And 81% of this age group uses an OTC pain medication.
In 2009, the alliance conducted a similar survey of adults age 60 and over. The results from the original survey showed that attitudes regarding access and restrictions to OTC pain relievers among those over age 60 have not changed. In both 2009 and 2014, 68% of respondents said they mostly use pain relievers that can be bought over-the-counter. In addition, an increasing number of respondents indicated that they believe it would be a bad idea for the FDA to change the policy to require a doctor’s prescription for extra-strength acetaminophen (66% in 2009 and 70% in 2014).
“Over the past five years, consumer views have been consistent — people support current availability of acetaminophen-containing OTC products and don’t want that access further restricted,” Bens said.
The survey results were compiled from landline and cell phone interviews with 1,600 Americans ages 18 and above. Results were divided between two age groups: 18-to-59 and those over the age of 60. The survey was conducted by Clarus Research Group with support from McNeil Consumer Healthcare.
Loading Post Please Wait...